Anticoagulation in COVID-19-Reference-Cited by-同舟云学术

Anticoagulation in COVID-19

Published:2020-04-30 Issue:4 Volume:6 Page:260-261
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Atallah Bassam¹²^ORCID,Mallah Saad I³^ORCID,AlMahmeed Wael⁴

Affiliation:

1. Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates

2. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA

3. School of Medicine, Royal College of Surgeons in Ireland–Bahrain, Kingdom of Bahrain

4. Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvaa036/33148493/pvaa036.pdf

Reference7 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. Incidence of thrombotic complications in critically ill ICU patients with COVID-19;Klok;Thromb Res,2020

3. [A pathological report of three COVID-19 cases by minimally invasive autopsies];Yao;Zhonghua Bing Li Xue Za Zhi,2020

4. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past;Giannis;J Clin Virol,2020

5. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy;Tang;J Thromb Haemost,2020

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and limitations of repurposed drugs and vaccines for COVID-19;Journal of Medicine, Surgery, and Public Health;2024-04

2. Analysis of factors affecting enoxaparin effectiveness on coagulation, inflammation, and clinical outcomes in patients with COVID-19;Journal of Pharmacy & Pharmacognosy Research;2023-11-01

3. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery;Genes & Diseases;2023-07

4. PBMC MicroRNAs: Promising Biomarkers for the Differential Diagnosis of COVID-19 Patients with Abnormal Coagulation Indices;Current Microbiology;2023-06-21

5. Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis;Diabetes & Metabolism Journal;2023-05-31